
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
---|---|---|---|---|---|---|
09/30/2025 | Q3 | $42.1B | -- | -- | $0.66 | -- |
08/05/2025 | Q2 | $43B | -- | -- | $0.70 | -- |
04/29/2025 | Q1 | $39.9B | $46.9B | $0.26 | $0.56 | -$0.31 |
02/11/2025 | Q4 | $45.6B | $45.8B | -$0.74 | $0.45 | -$1.19 |
10/29/2024 | Q3 | $45B | $47.3B | $0.07 | $0.79 | -$0.71 |
07/30/2024 | Q2 | $50.9B | $47.3B | -$0.05 | $0.91 | -$0.95 |
05/07/2024 | Q1 | $56.9B | $48.9B | $0.80 | $0.97 | -$0.17 |
02/06/2024 | Q4 | $56B | $52.1B | $0.13 | $1.00 | -$0.87 |
10/31/2023 | Q3 | -- | -- | $1.66 | $1.34 | $0.31 |
08/01/2023 | Q2 | -- | -- | $0.60 | $1.16 | -$0.56 |
05/02/2023 | Q1 | -- | -- | $2.70 | $1.42 | $1.28 |
02/07/2023 | Q4 | -- | -- | $3.50 | $1.65 | $1.85 |
11/01/2022 | Q3 | -- | -- | -$0.69 | $1.96 | -$2.65 |
08/02/2022 | Q2 | -- | -- | $2.83 | -- | -- |
05/03/2022 | Q1 | -- | -- | -$6.27 | -- | -- |
02/08/2022 | Q4 | -- | -- | $0.70 | -- | -- |
11/02/2021 | Q3 | -- | -- | -$0.76 | -- | -- |
08/03/2021 | Q2 | -- | -- | $0.92 | -- | -- |
04/27/2021 | Q1 | -- | -- | $1.37 | -- | -- |
02/02/2021 | Q4 | -- | -- | $0.40 | -- | -- |
10/27/2020 | Q3 | -- | -- | -$0.13 | -- | -- |
07/28/2020 | Q2 | -- | -- | -$5.00 | -- | -- |
04/28/2020 | Q1 | -- | -- | -$1.30 | -- | -- |
02/04/2020 | Q4 | -- | -- | $0.01 | -- | -- |
10/29/2019 | Q3 | -- | -- | -$0.22 | -- | -- |
07/30/2019 | Q2 | -- | -- | $0.54 | -- | -- |
04/30/2019 | Q1 | -- | -- | $0.87 | -- | -- |
02/05/2019 | Q4 | -- | -- | $0.23 | -- | -- |
10/30/2018 | Q3 | -- | -- | $1.00 | -- | -- |
07/31/2018 | Q2 | -- | -- | $0.84 | -- | -- |
05/01/2018 | Q1 | -- | -- | $0.74 | -- | -- |
02/06/2018 | Q4 | -- | -- | $0.01 | -- | -- |
10/31/2017 | Q3 | -- | -- | $0.53 | -- | -- |
08/01/2017 | Q2 | -- | -- | $0.04 | -- | -- |
05/02/2017 | Q1 | -- | -- | $0.44 | -- | -- |
02/07/2017 | Q4 | -- | -- | $0.16 | -- | -- |
11/01/2016 | Q3 | -- | -- | $0.51 | -- | -- |
07/26/2016 | Q2 | -- | -- | -$0.46 | -- | -- |
04/26/2016 | Q1 | -- | -- | -$0.19 | -- | -- |
02/02/2016 | Q4 | -- | -- | -$1.08 | -- | -- |
10/27/2015 | Q3 | -- | -- | $0.02 | -- | -- |
BP PLC reported $46.9B worth of top line sales in its most recent quarter.
BP PLC announced earnings per share of $0.26 which represents a miss of analyst forecast a $0.56 per share.
BP PLC reported $8.4B that represents $3.15 per share over the last quarter.
BP PLC's earnings are forecast to grow from $0.14 per share to $3.44 per share next year representing an increase of 1689.62%.
BP PLC's next earnings date is August 5, 2025.
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.